Log In
BCIQ
Print this Print this
 

rebastinib (DCC-2036)

  Manage Alerts
Collapse Summary General Information
Company Deciphera Pharmaceuticals LLC
DescriptionVascular endothelial growth factor (VEGF) receptor 1 (FLT1; VEGFR-1), tyrosine kinase receptor 2 (Tie2) and BCR-ABL tyrosine kinase inhibitor
Molecular Target BCR-ABL tyrosine kinase (BCR-ABL) ; Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1)
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 1 (Flt-1) kinase inhibitor; BCR-ABL tyrosine kinase inhibitor; Tyrosine kinase receptor 2 (Tie2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today